FlexPen®

DEVICE4 trials

Sponsors

Novo Nordisk A/S

Conditions

Delivery SystemsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Phase 1

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

CompletedNCT00127296

Novo Nordisk A/SDelivery Systems, Diabetes, Diabetes Mellitus, Type 2

Start: 2005-07-31End: 2005-09-30Updated: 2017-01-06

A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®

CompletedNCT02627287

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2015-12-01End: 2016-02-25Updated: 2018-02-07

Phase 3

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

CompletedNCT00773279

Novo Nordisk A/SDelivery Systems, Diabetes, Diabetes Mellitus, Type 1 +1

Start: 2008-09-30End: 2009-06-30Updated: 2017-03-27

Unknown Phase

Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

CompletedNCT01454024

Novo Nordisk A/SDelivery Systems, Diabetes, Diabetes Mellitus, Type 1 +1

Start: 2011-11-30End: 2012-10-31Updated: 2015-06-12

Related Papers

Injecting without pressing a button: An exploratory study of a shield‐triggered injection mechanism

Diabetes Obesity and Metabolism2017-12-273 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01